Supernus Pharmaceuticals Inc
Closed
SectorHealthcare
48.12 -0.08
Overview
Share price change
24h
Min
47.49
Max
49.02
Income | 36M -2.3M |
|---|---|
Sales | -3.9M 208M |
EPS | 0.21 |
Profit margin | -1.104 |
Employees | 778 |
EBITDA | -70M 20M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +31.72% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | -64M 2.7B |
|---|---|
Previous open | 48.2 |
Previous close | 48.12 |
News Sentiment
By Acuity
68%
32%
298 / 340 Healthcare
Supernus Pharmaceuticals Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Supernus Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 63.5 USD 31.72%
High 67 USD
Low 55 USD
Based on 6 Wall Street analysts offering 12 month price targets forSupernus Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$